Read + Share
Amedeo Smart
Independent Medical Education
Weng X, Huang X, Li H, Lin S, et al. First-Line Treatment With Atezolizumab Plus Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis. Am J Clin Oncol 2020 Feb 5. doi: 10.1097/COC.0000000000000671.PMID: 32028340
Email
LinkedIn
Facebook
Twitter
Privacy Policy